AXA Shares Limit Losses at Close, RSI in Overbought Zone

Session Close and Stock Performance

AXA's stock ended the session at 40.81 euros, down 0.44% from the previous close of 40.99 euros. This slight decrease occurred in a context of low activity, with only 0.06% of the capital traded during the day. Over a longer term, the stock shows a positive dynamic with a 4% increase over seven days and 3.13% over three months. The annual performance remains particularly strong with a gain of 20.95%, reflecting investor confidence in Europe's leading insurance group. This increase is particularly supported by the publication at the end of October of solid results for the third quarter of 2025, with a turnover of 89.4 billion euros, up 7% over nine months. The Solvency II ratio stands at 222%, two points above the consensus, reflecting the financial strength of the group. UBS has maintained its buy recommendation with a target price of 45 euros, while KBW raised its target to 47 euros on December 9 with an outperform recommendation. These positions contrast with AlphaValue's downgrade at the end of November, which lowered its target from 50 to 44.90 euros while maintaining an accumulate recommendation.

Technical Analysis Insights

Technical analysis reveals a relative strength index at 76, well above the overbought threshold set at 70. This indicator suggests that the stock may undergo a consolidation phase in the short term following the recent sharp rise. The RSI is in the overbought zone, indicating a potential short-term technical correction as several recent technical analyses suggest. The current price of 40.81 euros is above the 50-day moving average of 38.95 euros and nearly at the level of the 200-day moving average of 40.31 euros. This configuration confirms a medium-term bullish trend but also highlights the proximity to a major technical resistance threshold. The stock is also moving between its upper Bollinger band at 40.90 euros and its lower band at 37.23 euros, dangerously approaching the upper limit of this channel. The MACD shows mixed signals with a main line at 0.54 above the signal line at 0.27, and a positive histogram at 0.27 confirming a short-term bullish momentum. However, the monthly volatility measured at 3.07% remains moderate, suggesting that movements in the stock should remain contained in the coming sessions.

Operational Context and Strategic Moves

The operational context remains favorable for AXA, which finalized the acquisition of 51% of the Italian insurer Prima for 0.5 billion euros at the beginning of December. This transaction is part of the group's external growth strategy and is expected to impact the Solvency II ratio by 6 points according to official communications. The group aims for an average annual growth in operating income per share of 6% to 8% between 2023 and 2026. AXA IM Alts, the group's alternative investments division, also acquired 40% of FiberPass, a Spanish fiber optic operator, from Telefónica and Vodafone at the end of November. This operation brings AXA IM Alts' equity infrastructure investments to over 700 million euros in 2025. These acquisitions demonstrate the group's ability to deploy its capital in strategic assets while maintaining high financial solidity. The next appointment for investors will be the publication of the 2025 annual results scheduled for February 26, 2026, followed by the general assembly on April 30, 2026. The stock is currently trading above its support at 37.51 euros and just at its resistance level at 40.99 euros, leaving little room for upward movement in the very short term without a confirmed breach of this technical ceiling.